![](https://www.brain-biotech.com/sized/images/News/10933224/C19A8785_cover_v2_a3ddd0ff13b9f69e4cabb11338326a85.jpg 1480w 833h, https://www.brain-biotech.com/sized/images/News/10933224/C19A8785_cover_v2_c08c0aed2c68af41e95a855ac0751273.jpg 1216w 684h, https://www.brain-biotech.com/sized/images/News/10933224/C19A8785_cover_v2_c3982973ccc3a064847f5a918aee8648.jpg 992w 558h, https://www.brain-biotech.com/sized/images/News/10933224/C19A8785_cover_v2_56bc6d3f51cfa5f5412cac2ec9c4cb42.jpg 768w 432h, https://www.brain-biotech.com/sized/images/News/10933224/C19A8785_cover_v2_a45055c2606cebb432b0b8e7ecf68218.jpg 576w 324h, https://www.brain-biotech.com/sized/images/News/10933224/C19A8785_cover_v2_079d427c1a483516a693d94d0fd7857c.jpg 400w 225h)
"An ESG report should not be justified in itself"
BRAIN Biotech AG published in mid-June its first sustainability report and initial ESG data. We asked our colleague Michael Schneiders, Head of IR and Sustainability, about the background, challenges and next steps in sustainability at BRAIN.